INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
$36.61 -0.5 (-1.3473%)
Analysed INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) News Sources
IMVT's Q4 Loss Wider Than Expected, Stock Up 35% on Strong Study Data
21-05-2026
yahoo.com
Does Indivior Pharmaceuticals Inc. (INDV) Have the Potential to Rally 32.48% as Wall Street Analysts Expect?
21-05-2026
yahoo.com
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know
21-05-2026
yahoo.com
Dyne Stock Gains 10% on Initiation of Late-Stage Study in DMD Patients
21-05-2026
yahoo.com
Here's Why You Should Add Altimmune Stock to Your Portfolio Now
22-05-2026
yahoo.com
BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data
25-05-2026
yahoo.com
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe
25-05-2026
yahoo.com
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy
27-05-2026
yahoo.com
CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up
28-05-2026
yahoo.com
TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study
28-05-2026
yahoo.com
What is the current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is $36.61.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) absolute price change since previous trading day?
The absolute price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is $-0.5.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) percentage price change since previous trading day?
The percentage price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is -1.3473%.
What is the most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is 42 out of 100.
What is the most recent average sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is .
SEC-8K** Filing Available For INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.